FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis ...

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets ...